- Home
- CLST vs RFL Comparison
CLST vs RFL Comparison
Compare CLST & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- RFL
- Stock Information
- Founded
- CLST 1922
- RFL 2017
- Country
- CLST United States
- RFL United States
- Employees
- CLST N/A
- RFL N/A
- Industry
- CLST
- RFL Real Estate
- Sector
- CLST
- RFL Finance
- Exchange
- CLST Nasdaq
- RFL Nasdaq
- Market Cap
- CLST 52.2M
- RFL 48.4M
- IPO Year
- CLST N/A
- RFL N/A
- Fundamental
- Price
- CLST $11.40
- RFL $1.97
- Analyst Decision
- CLST
- RFL
- Analyst Count
- CLST 0
- RFL 0
- Target Price
- CLST N/A
- RFL N/A
- AVG Volume (30 Days)
- CLST 11.6K
- RFL 46.5K
- Earning Date
- CLST 10-24-2024
- RFL 10-28-2024
- Dividend Yield
- CLST N/A
- RFL N/A
- EPS Growth
- CLST N/A
- RFL N/A
- EPS
- CLST N/A
- RFL N/A
- Revenue
- CLST $4,388,000.00
- RFL $540,000.00
- Revenue This Year
- CLST N/A
- RFL N/A
- Revenue Next Year
- CLST N/A
- RFL N/A
- P/E Ratio
- CLST N/A
- RFL N/A
- Revenue Growth
- CLST N/A
- RFL 92.86
- 52 Week Low
- CLST $10.60
- RFL $1.29
- 52 Week High
- CLST $12.10
- RFL $2.14
- Technical
- Relative Strength Index (RSI)
- CLST 53.65
- RFL 73.60
- Support Level
- CLST $11.30
- RFL $1.65
- Resistance Level
- CLST $11.46
- RFL $1.99
- Average True Range (ATR)
- CLST 0.20
- RFL 0.10
- MACD
- CLST 0.06
- RFL 0.02
- Stochastic Oscillator
- CLST 75.95
- RFL 96.00
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.